Oh, and go against all the standard of care options that achieve meaningful ORRs while being used IV and who have dominated the market for years...? Good luck.
You are scrambling to make sense of a bad investment and not doing your homework when IMU was pivoting to OV therapy.
Also, the global FTO inhibitor market IS $0. It doesn't exist, which is why the opportunity is so large. First to market with a new CLASS of drug makes significantly more than me toos. While I'm at it, the global cardiosynergy market IS also $0 because it also doesn't exist.
Read the paper below and don't stop reading it until why HERVAXX was destined to fail commercially sinks in.
https://www.nature.com/articles/d41573-023-00048-2
Oh, and go against all the standard of care options that achieve...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $400.2K | 8.603M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1876197 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 613421 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |